Avoiding PI Ethical Dilemmas In Clinical Research BONUS Ep 188

When it comes to consent, the FDA will always take note of any potential threats to patient safety. Nevertheless, there are physicians who change their patient prescriptions before a study starts to ensure that the patient will qualify for a study. While making such changes may not seem harmful, failing to document legitimate reasons for the change can quickly cause FDA officials to become suspicious.

Comment